News
Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...
Hosted on MSN11m
Roche pauses Sarepta gene therapy shipments outside the U.S.
approved for a neuromuscular disorder called Duchenne muscular dystrophy. Last week, the U.S. biotech initially rejected the request, which came after Elevidys and another gene therapy from the ...
InvestorsHub on MSN50m
Precision BioSciences shares climb after FDA grants orphan drug status
Precision BioSciences (NASDAQ:DTIL) saw its stock rise 5% following the announcement that the U.S. Food and Drug ...
A new biotech called Dispatch Bio launched today with the goal of developing a new, universal approach to try to treat any cancer using immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback